Detailing how Australia’s Therapeutics Goods Administration conducted horizon scanning for new vaccines during the pandemic to assist ADB, this report is designed to help countries in Asia and the Pacific prepare for future outbreaks. It provides details of 16 vaccine manufacturers with novel and established vaccine technologies adapted to new pathogens like SARS-CoV-2, the virus that causes COVID-19. Offering information on their vaccine pipeline and partnerships, the report shows their approach to working with ADB’s developing member countries and can be used to inform decisions related to vaccine manufacturing and procurement.